developing biomarkers and treatments for chronic joint diseases
PROJECTS
Project overview
Drug development
Biomarker development
NEWS & REPORTS
CORPORATE OVERVIEW
About AnaMar
Competitive Advantages
Strategic Priorities
Senior management
Board of directors
Address, phone & fax
Contact us
Search
«
Back
|
Home
»
News & Reports
»
Latest News
AnaMar News
Positive Phase I results for AMAP102
01 Jun 2010, News
The AMAP102 Phase I study has been completed with positive results.
Read more
Positive Phase I results for AMAP102
01 Jun 2010, News
New COMP ELISA Focus letter
26 Mar 2010, News
AMAP102, New Oral Cytokine Inhibitor to Treat Rheumatoid Arthritis - Phase 1 dosing completed , Results in Q1
01 Dec 2009, News
Company name change
01 Dec 2009, News
Innovation in Autoimmune Diagnostics - Visit AnaMar´s new website for INOVA´s Swedish customers!
30 Nov 2009, News
AnaMar News
> Latest News
> Press releases
> Sign up for RSS-feeds
Financial reports
> Annual report 2008
> Annual report 2007
> Annual report 2006
> Annual report 2005
> Annual report 2004
Publications
> Abstract ACR 2009
> Abstract EULAR 2009
> Abstract ACR 2007
Press images
> People
> Logo
©
2010, AnaMar AB, Kungsportsavenyn 22, SE-411 36, Göteborg, Sweden. Phone: +46 31 732 41 40, Fax: +46 31 732 41 49,
info@anamar.com
Disclaimer
-
Privacy policy statement
-
Terms and conditions of use
